susceptibility of carbapenem resistant Enterobacterales to meropenem-vaborbactam and ceftazidime-avibactam at a single academic medical centre.

Background: Carbapenem-resistant Enterobacterales (CRE) are considered an urgent threat. Ceftazidime-avibactam and meropenem-vaborbactam contain β-lactamase inhibitors active against CRE isolates including those that produce carbapenemases (KPC).

Methods: Retrospective chart review of CRE isolates from 1 January 2016 to 1 November 2018.

Introducing antimicrobial stewardship to the outpatient clinics of a suburban academic health system.

Objective: To establish an antimicrobial stewardship program in the outpatient setting.

Design: Prescribers of antimicrobials were asked to complete a survey regarding antimicrobial stewardship. We also monitored their compliance with appropriate prescribing practices, which were shared in monthly quality improvement reports.